UConn developing system for treating depression
University of Connecticut professor of computer science and engineering Bing Wang is the lead principal investigator on a new $1 million grant from the National...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
University of Connecticut professor of computer science and engineering Bing Wang is the lead principal investigator on a new $1 million grant from the National...
Connecticut Innovations, Connecticut’s strategic venture capital arm, has announced the finalists for VentureClash, the $5 million global venture challenge. The 10 finalists will participate in a...
Biohaven said in a recent regulatory filing that the FDA has accepted its new drug application for treatment and prevention of migraine headaches. The filing...
Insperity, a small business consultant for more than 30 years, provides an array of human resource solutions designed to restructure operations and streamline performance. Insperity...
Vanessa Research (VRI) has acquired Hungaro-Gal, a Hungarian pharmaceutical contract manufacturing company. Per the acquisition, VRI will continue Hungaro-Gal’s contract manufacturing services and intends to maintain...
Arvinas has announced that six new thought leaders will join the company’s scientific advisory board. The new members are Tomasz M. Beer, M.D., F.A.C.P., Adam L....
JAX and UConn researchers are exploring how patients’ microbiome, and risk of infection, change after time in a skilled nursing facility. A $778,801 grant from the National...
Two years ago, Erika R. Smith left her job as director of the Blavatnik Fund for Innovation at Yale to become chief executive officer of...
An experimental ALS drug being developed in New Haven will be tested next year in a first-of-its-kind clinical trial led by Massachusetts General Hospital. Biohaven Pharmaceuticals’...
Bayer and Arvinas have launched a new company, Oerth Bio, to leverage Arvinas’ expertise in targeted protein degradation and Bayer’s experience in developing human therapies and...